Protecting Access to Affordable Medicines Act of 2020

United States116th CongressHR-8529House of Representatives
Updated: Oct 6, 2020

Summary

Protecting Access to Affordable Medicines Act of 2020 This bill prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

All available records shown.